Abstract
The present invention relates to polypeptides and uses thereof for reducing CD95-meditated cell motility. In particular, the present invention relates to a polypeptide having an amino acid sequence having at least 70% of identity with the amino acid sequence ranging from the amino-acid residue at position 175 to the amino-acid residue at position 191 in SEQ ID NO:1.
| Original language | English (Ireland) |
|---|---|
| Patent number | US10556941B2 |
| Filing date | 10/10/2018 |
| Publication status | Published - 02 Nov 2020 |